Preface |
|
xvii | |
About the Author |
|
xxi | |
Acronyms and Abbreviations |
|
xxiii | |
1 Introduction to Noninvasive Medical Measurements |
|
1 | (4) |
|
1.1 Definitions of Noninvasive, Minimally Invasive, and Invasive Medical Measurements |
|
|
1 | (1) |
|
1.2 Modalities of NI Instrumentation |
|
|
2 | (2) |
|
|
4 | (1) |
2 Visual Inspection of Tissues with Certain Endoscopes and Other Optical Devices |
|
5 | (16) |
|
|
5 | (1) |
|
2.2 Ophthalmoscopes, Slit Lamps, and Otoscopes |
|
|
5 | (4) |
|
|
5 | (3) |
|
|
8 | (1) |
|
|
8 | (1) |
|
|
9 | (5) |
|
2.4 CCD and CMOS Active Pixel Image Sensors |
|
|
14 | (3) |
|
|
14 | (2) |
|
2.4.2 CMOS Active Pixel Image Sensors |
|
|
16 | (1) |
|
2.5 NI Diagnosis of Skin Lesions |
|
|
17 | (2) |
|
|
17 | (1) |
|
|
17 | (2) |
|
|
19 | (1) |
|
|
19 | (2) |
3 Noninvasive Diagnosis Using Sounds Originating from within the Body |
|
21 | (22) |
|
|
21 | (7) |
|
|
21 | (1) |
|
|
21 | (2) |
|
|
23 | (2) |
|
|
25 | (1) |
|
|
26 | (2) |
|
3.2 Means of Analysis for Acoustic Signals |
|
|
28 | (5) |
|
|
28 | (1) |
|
3.2.2 Discrete Fourier Transform and the Power Density Spectrum |
|
|
28 | (3) |
|
3.2.3 Time-Frequency Analysis for Transient Sounds |
|
|
31 | (2) |
|
|
33 | (1) |
|
|
33 | (5) |
|
|
33 | (2) |
|
3.3.2 Abnormal Heart Sounds |
|
|
35 | (3) |
|
|
38 | (1) |
|
|
38 | (2) |
|
|
38 | (1) |
|
3.4.2 Abnormal Breath Sounds |
|
|
38 | (1) |
|
|
39 | (1) |
|
3.5 Otoacoustic Emissions |
|
|
40 | (1) |
|
|
40 | (1) |
|
3.5.2 Otoacoustic Testing |
|
|
40 | (1) |
|
|
41 | (1) |
|
|
41 | (2) |
4 Measurement of Electrical Potentials and Magnetic Fields from the Body Surface |
|
43 | (72) |
|
|
43 | (1) |
|
|
43 | (5) |
|
|
43 | (1) |
|
4.2.2 Electrode Half-Cell Potential |
|
|
44 | (1) |
|
4.2.3 Equivalent Circuits for AgC1 Skin Electrodes |
|
|
45 | (1) |
|
|
46 | (2) |
|
4.2.5 Invasive Electrodes |
|
|
48 | (1) |
|
4.3 Biopotential Amplifiers |
|
|
48 | (21) |
|
|
48 | (1) |
|
4.3.2 Single-Ended Input Amplifiers |
|
|
48 | (1) |
|
4.3.3 Differential Amplifiers |
|
|
49 | (4) |
|
4.3.4 Op-amps Used for Signal Conditioning |
|
|
53 | (2) |
|
4.3.5 Noise and Low-Noise Amplifiers |
|
|
55 | (8) |
|
4.3.6 Medical Isolation Amplifiers |
|
|
63 | (4) |
|
4.3.7 Driven-Leg ECG Amplifiers |
|
|
67 | (2) |
|
|
69 | (1) |
|
|
69 | (9) |
|
|
69 | (1) |
|
4.4.2 Electrode Placements |
|
|
70 | (5) |
|
4.4.3 Vector Cardiography |
|
|
75 | (1) |
|
4.4.4 ECG Analysis, Feature Extraction, and Diagnosis |
|
|
76 | (1) |
|
|
77 | (1) |
|
|
78 | (6) |
|
|
78 | (1) |
|
|
79 | (2) |
|
|
81 | (1) |
|
4.5.4 What EMGs Can Tell Us |
|
|
82 | (2) |
|
|
84 | (1) |
|
|
84 | (10) |
|
|
84 | (1) |
|
4.6.2 Sources and Classification of the EEG |
|
|
84 | (1) |
|
4.6.3 EEG Recording Systems |
|
|
85 | (2) |
|
4.6.4 2-D Spatial Sampling of Scalp EEG Potentials by Electrode Arrays |
|
|
87 | (4) |
|
4.6.5 EEG Amplifiers, Interfaces, and Signal Processing |
|
|
91 | (1) |
|
4.6.6 Event-Related Potentials and Signal Averaging |
|
|
92 | (2) |
|
|
94 | (1) |
|
4.7 Other Body Surface Potentials |
|
|
94 | (8) |
|
|
94 | (1) |
|
|
95 | (1) |
|
|
95 | (4) |
|
|
99 | (1) |
|
|
100 | (2) |
|
4.8 Magnetoelectric Measurements |
|
|
102 | (10) |
|
4.8.1 Introduction: SQUID and SQUID Arrays |
|
|
102 | (2) |
|
4.8.2 Magnetoencephalogram |
|
|
104 | (4) |
|
4.8.3 Magnetocardiography Using SQUIDS |
|
|
108 | (1) |
|
4.8.4 Other Magnetoelectric Measurements |
|
|
109 | (1) |
|
4.8.5 Optical Atomic Magnetometers |
|
|
109 | (2) |
|
|
111 | (1) |
|
|
112 | (3) |
5 Noninvasive Measurements of Blood Pressure |
|
115 | (4) |
|
|
115 | (1) |
|
5.2 Cuff Sphygmomanometer |
|
|
115 | (2) |
|
5.3 Other-Means of Noninvasively Estimating BP |
|
|
117 | (1) |
|
|
117 | (2) |
6 Body Temperature Measurements |
|
119 | (12) |
|
|
119 | (1) |
|
6.2 Conductive Heat Transfer and Thermometer Response Time |
|
|
120 | (1) |
|
|
121 | (8) |
|
|
121 | (1) |
|
6.3.2 Physics of BB Radiation |
|
|
122 | (2) |
|
6.3.3 Temperature Measurement with PYMs |
|
|
124 | (3) |
|
6.3.4 ThermoScan LIR Thermometers |
|
|
127 | (2) |
|
|
129 | (1) |
|
|
129 | (2) |
7 Noninvasive Blood Gas Sensing with Electrodes |
|
131 | (8) |
|
|
131 | (1) |
|
7.2 Transcutaneous O2 Sensing |
|
|
131 | (2) |
|
7.2.1 Introduction: The Clark Electrode |
|
|
131 | (2) |
|
7.2.2 Transcutaneous [ O2] (tcpO2) Sensor |
|
|
133 | (1) |
|
7.3 Transcutaneous CO2 Sensing |
|
|
133 | (2) |
|
7.3.1 Introduction: The Stow-Severinghaus Electrode |
|
|
133 | (2) |
|
7.3.2 Transcutaneous tcpCO2 Sensing |
|
|
135 | (1) |
|
|
135 | (4) |
8 Tests on Naturally Voided Body Fluids |
|
139 | (44) |
|
|
139 | (1) |
|
|
139 | (34) |
|
|
139 | (1) |
|
8.2.2 Dispersive Spectrophotometry |
|
|
139 | (8) |
|
8.2.3 Nondispersive Spectroscopy |
|
|
147 | (5) |
|
8.2.4 Chemical Analysis by SPR |
|
|
152 | (6) |
|
8.2.5 Ion-Selective Electrodes |
|
|
158 | (2) |
|
|
160 | (4) |
|
|
164 | (4) |
|
|
168 | (5) |
|
8.3 What Can Be Learned from Urine? |
|
|
173 | (4) |
|
|
173 | (4) |
|
8.3.2 Diagnosis of Early-Stage Pancreatic Cancer from Proteins in the Urine |
|
|
177 | (1) |
|
8.4 What Can Be Learned from Feces? |
|
|
177 | (2) |
|
8.5 What Can Be Learned from Saliva? |
|
|
179 | (1) |
|
8.6 What Can Be Learned from Breath? |
|
|
180 | (2) |
|
|
182 | (1) |
9 Plethysmography |
|
183 | (8) |
|
|
183 | (1) |
|
9.2 Volume Displacement Plethysmography |
|
|
183 | (1) |
|
9.3 Impedance Plethysmography |
|
|
183 | (7) |
|
|
183 | (1) |
|
9.3.2 Self-Balancing, Impedance Plethysmographs |
|
|
184 | (5) |
|
9.3.3 Applications of Impedance Plethysmography |
|
|
189 | (1) |
|
|
190 | (1) |
|
9.4 Photo-Plethysmography |
|
|
190 | (1) |
|
|
190 | (1) |
10 Pulmonary Function Tests |
|
191 | (10) |
|
|
191 | (1) |
|
10.2 Spirometers and Related Equipment |
|
|
192 | (3) |
|
10.3 Tests with Spirometers |
|
|
195 | (3) |
|
10.4 Diffusing Capacity of the Lungs for Carbon Monoxide |
|
|
198 | (1) |
|
|
199 | (2) |
11 Measurement of Basal Metabolism |
|
201 | (4) |
|
|
201 | (1) |
|
|
202 | (1) |
|
|
203 | (2) |
12 Ocular Tonometry |
|
205 | (6) |
|
|
205 | (1) |
|
12.2 Noncontact, Air-Puff Applanation Tonometer |
|
|
206 | (3) |
|
|
209 | (1) |
|
|
210 | (1) |
13 Noninvasive Tests Involving the Input of Audible Sound Energy |
|
211 | (16) |
|
|
211 | (2) |
|
13.2 Acoustic Impedance Measurement of the Respiratory System |
|
|
213 | (3) |
|
13.3 Acoustic Impedance Measurement of the Eardrum (Tympanometry) |
|
|
216 | (5) |
|
13.4 Transthoracic Acoustic Transfer Function as a Possible Measure of Lung Condition |
|
|
221 | (4) |
|
|
221 | (2) |
|
13.4.2 Transthoracic Propagation of Broadband Acoustic Noise to Evaluate Pulmonary Health |
|
|
223 | (1) |
|
13.4.3 Use of White Noise Sound Introduced into the Oral Airway to Assess Lung Condition |
|
|
224 | (1) |
|
|
225 | (1) |
|
|
225 | (2) |
14 Noninvasive Tests Using Ultrasound (Excluding Imaging) |
|
227 | (28) |
|
|
227 | (1) |
|
|
227 | (1) |
|
14.3 Doppler Ultrasound for Blood and Tissue Velocity Measurements |
|
|
228 | (10) |
|
14.3.1 Angle-Dependent, CW, Blood Velocity Magnitude Measurement |
|
|
228 | (2) |
|
14.3.2 Directional, CW Doppler System |
|
|
230 | (3) |
|
14.3.3 Angle-Independent, CW Doppler Velocimetry |
|
|
233 | (1) |
|
14.3.4 Pulsed Doppler Systems |
|
|
234 | (4) |
|
|
238 | (1) |
|
|
238 | (8) |
|
|
238 | (2) |
|
14.4.2 Closed-Loop, Constant-Phase, No Touch Means of Measurement of OP |
|
|
240 | (5) |
|
|
245 | (1) |
|
14.5 Closed-Loop, Type 1, Constant-Phase Difference Ranging System |
|
|
246 | (5) |
|
|
246 | (1) |
|
14.5.2 Analysis of a Linear NOTOPM System Using a VPC |
|
|
247 | (3) |
|
14.5.3 Other Applications of the CPDRS Architecture Using Ultrasound |
|
|
250 | (1) |
|
|
250 | (1) |
|
14.6 Measurement of Tissue Glucose Concentration By Closed-Loop, Constant-Phase, CW Ultrasound: A Prototype System |
|
|
251 | (3) |
|
|
251 | (1) |
|
14.6.2 Approximate Model of How c Varies with Density, p |
|
|
251 | (1) |
|
14.6.3 Phase Lag between the Transmitted and Received CW Ultrasound Waves |
|
|
252 | (1) |
|
14.6.4 System Block Diagram for the Constant-Phase Glucose Sensor System |
|
|
252 | (2) |
|
|
254 | (1) |
|
|
254 | (1) |
15 Noninvasive Applications of Photon Radiation (Excluding Imaging) |
|
255 | (54) |
|
|
255 | (1) |
|
|
256 | (3) |
|
|
256 | (1) |
|
|
256 | (3) |
|
|
259 | (1) |
|
15.3 NI Diagnosis By Tissue Fluorescence |
|
|
259 | (4) |
|
|
259 | (1) |
|
15.3.2 Properties of Fluorescent Molecules |
|
|
260 | (1) |
|
15.3.3 Fluorescence in NI Cancer Diagnosis |
|
|
260 | (3) |
|
|
263 | (1) |
|
15.4 Optical Interferometric Measurement of Nanometer Displacements of Biological Surfaces |
|
|
263 | (6) |
|
|
263 | (2) |
|
15.4.2 Measurement of Tympanal Membrane Displacement By Fizeau Interferometer |
|
|
265 | (1) |
|
15.4.3 Measurement of Skin Vibration By Optical Interferometry |
|
|
266 | (3) |
|
|
269 | (1) |
|
15.5 Laser Doppler Velocimetry |
|
|
269 | (8) |
|
|
269 | (2) |
|
15.5.2 LDV Applied to Retinal Blood Vessels |
|
|
271 | (4) |
|
15.5.3 LDV Applied to Skin and Other Tissues |
|
|
275 | (2) |
|
|
277 | (1) |
|
|
277 | (8) |
|
|
277 | (2) |
|
15.6.2 Direct Measurement of Blood Glucose with IR Spectrosopy |
|
|
279 | (1) |
|
15.6.3 Transcutaneous Measurement of Glucose with IR |
|
|
280 | (5) |
|
|
285 | (1) |
|
15.7 Estimation of Blood Glucose from NI Measurement of Optical Rotation of the Aqueous Humor of the Eye (a Prototype System) |
|
|
285 | (9) |
|
|
285 | (1) |
|
15.7.2 Open-Loop Gilham Microdegree Polarimeter |
|
|
286 | (3) |
|
15.7.3 Dynamics and Sensitivity of the Closed-Loop Polarimeter |
|
|
289 | (2) |
|
15.7.4 Application of the Modified Gilham Polarimeter to the Measurement of the Optical Rotation of Aqueous Humor in a Model System |
|
|
291 | (2) |
|
|
293 | (1) |
|
15.8 Semi-Invasive, Continuous Measurement of Blood Glucose Using Subcutaneous Sensors |
|
|
294 | (2) |
|
|
294 | (1) |
|
15.8.2 Biorasis Inc. Glucowizzard Subcutaneous Continuous Glucose Monitoring |
|
|
294 | (2) |
|
|
296 | (5) |
|
|
296 | (1) |
|
15.9.2 Pulse Oximetry Systems |
|
|
297 | (4) |
|
|
301 | (1) |
|
15.10 NI Measurement of Certain Biomolecules By Raman Spectroscopy |
|
|
301 | (6) |
|
|
301 | (3) |
|
15.10.2 Diagnostic Applications of Raman Spectroscopy |
|
|
304 | (2) |
|
|
306 | (1) |
|
|
307 | (2) |
16 A Survey of Medical Imaging Systems |
|
309 | (60) |
|
|
309 | (1) |
|
|
309 | (12) |
|
|
309 | (1) |
|
16.2.2 Sources of Medical X-rays |
|
|
309 | (4) |
|
16.2.3 X-ray Detectors and Recording Media |
|
|
313 | (5) |
|
|
318 | (3) |
|
16.2.5 Mammography with Ultrasound |
|
|
321 | (1) |
|
|
321 | (10) |
|
|
321 | (3) |
|
16.3.2 Formation of Tomograms with the Algebraic Reconstruction Technique |
|
|
324 | (3) |
|
16.3.3 Use of the RT in Tomography |
|
|
327 | (4) |
|
16.4 Positron Emission Tomography |
|
|
331 | (5) |
|
|
331 | (1) |
|
|
331 | (4) |
|
16.4.3 Some PET Applications |
|
|
335 | (1) |
|
16.5 Magnetic Resonance Imaging |
|
|
336 | (4) |
|
|
336 | (1) |
|
|
336 | (2) |
|
|
338 | (1) |
|
16.5.4 MRI Contrast Agents |
|
|
339 | (1) |
|
16.6 Single-Photon Emission Tomography |
|
|
340 | (8) |
|
|
340 | (1) |
|
16.6.2 Radiochemicals Used in SPECT |
|
|
341 | (1) |
|
16.6.3 Scintillation Crystals Used in Nuclear Medicine |
|
|
342 | (1) |
|
16.6.4 Gamma Cameras and Collimators |
|
|
342 | (2) |
|
16.6.5 Future Trends in Nuclear Medical Imaging |
|
|
344 | (4) |
|
16.7 Optical Coherence Tomography |
|
|
348 | (5) |
|
|
348 | (1) |
|
|
348 | (2) |
|
16.7.3 Applications of OCT |
|
|
350 | (3) |
|
|
353 | (8) |
|
|
353 | (1) |
|
16.8.2 Physics of Ultrasound Propagation in Solids and Liquids |
|
|
353 | (3) |
|
16.8.3 Ultrasound Transducers |
|
|
356 | (3) |
|
16.8.4 Doppler Ultrasound Imaging |
|
|
359 | (2) |
|
16.9 Other Imaging Modalities |
|
|
361 | (6) |
|
|
361 | (1) |
|
16.9.2 LIR Thermal Imaging of Body Surfaces |
|
|
361 | (2) |
|
|
363 | (1) |
|
16.9.4 EIT in 2-D Imaging |
|
|
364 | (3) |
|
|
367 | (2) |
17 Innovations in Noninvasive Instrumentation and Measurements |
|
369 | (30) |
|
|
369 | (1) |
|
17.2 DNA Analysis by Polymerase Chain Reaction |
|
|
370 | (1) |
|
17.3 DNA Sequencing with Nanopores |
|
|
371 | (1) |
|
17.4 Fluorescence Tests for Biomolecules: FISH and SKY |
|
|
372 | (1) |
|
|
373 | (3) |
|
17.6 Analytical Microarrays |
|
|
376 | (5) |
|
|
376 | (1) |
|
|
376 | (1) |
|
17.6.3 Nucleic Acid Microarrays |
|
|
377 | (2) |
|
17.6.4 Peptide and Protein Microarrays |
|
|
379 | (1) |
|
17.6.5 Glycan Microarrays |
|
|
380 | (1) |
|
17.6.6 Lectin Microarrays |
|
|
380 | (1) |
|
17.7 NI Chemical Tests for Cancer Not Involving DNA |
|
|
381 | (5) |
|
|
381 | (1) |
|
17.7.2 Melatonin and Cancer |
|
|
381 | (1) |
|
17.7.3 Pteridines and Cancer: Other Chemical Tests |
|
|
382 | (2) |
|
17.7.4 GM Bacteria for NI tumor Detection |
|
|
384 | (1) |
|
17.7.5 In Vitro Magnetic Levitation of Single Cells for Cancer Detection |
|
|
384 | (1) |
|
17.7.6 Use of Circularly Polarized Light for NI Cancer Detection |
|
|
385 | (1) |
|
17.8 Minimally Invasive Sensors Using Drops of Blood |
|
|
386 | (6) |
|
|
386 | (1) |
|
17.8.2 Malaria Parasite Detection Using Magnetic Resonance Relaxometry of Hemozoin in Blood |
|
|
386 | (3) |
|
17.8.3 Colorimetric and Redox Blood Glucose Sensors |
|
|
389 | (1) |
|
17.8.4 Blood Clotting Time (INR) Measurement |
|
|
389 | (1) |
|
17.8.5 Scanning Confocal Microscopy |
|
|
390 | (2) |
|
17.8.6 Liquid Biopsies and the Detection of Cancer |
|
|
392 | (1) |
|
17.9 Blood Alcohol Concentration Estimation by Breathalyzer |
|
|
392 | (3) |
|
17.9.1 BAC Estimation by Measuring Transdermal Alcohol Concentration Using Wearable Sensors |
|
|
394 | (2) |
|
|
394 | (1) |
|
|
394 | (1) |
|
|
395 | (1) |
|
17.11 Use of Diffuse Reflectance Imaging to Detect Oral Cancer |
|
|
396 | (1) |
|
|
396 | (1) |
|
17.11.2 DRI System Design and Applications |
|
|
396 | (1) |
|
17.12 Coregistered Photoacoustic and Ultrasound Imaging |
|
|
396 | (1) |
|
|
397 | (2) |
18 Introduction to Noninvasive Therapies |
|
399 | (26) |
|
|
399 | (1) |
|
18.2 Brain Stimulation Therapies |
|
|
399 | (4) |
|
|
399 | (1) |
|
18.2.2 Repetitive Transcranial Magnetic Stimulation |
|
|
399 | (2) |
|
18.2.3 Transcranial DC Stimulation |
|
|
401 | (1) |
|
18.2.4 Electroconvulsive Therapy |
|
|
401 | (2) |
|
|
403 | (1) |
|
18.3 Treatment of Osteoarthritis with US |
|
|
403 | (1) |
|
|
403 | (1) |
|
18.3.2 US Treatment of OA |
|
|
404 | (1) |
|
18.4 Radiation Therapy versus Cancers |
|
|
404 | (1) |
|
|
404 | (1) |
|
|
405 | (1) |
|
18.5 TTF: LF AC Electromagnetic Field Stimulation to Fight Glioblastomas |
|
|
405 | (1) |
|
18.6 Transcutaneous Electrical Nerve Stimulation |
|
|
406 | (1) |
|
|
407 | (1) |
|
18.8 Interferential Current Therapy |
|
|
408 | (3) |
|
|
408 | (2) |
|
18.8.2 Applications of ICT |
|
|
410 | (1) |
|
18.8.3 Other forms of ICT |
|
|
410 | (1) |
|
18.8.4 Electrode Placement for ICT |
|
|
411 | (1) |
|
18.9 Electrical and Magnetic Stimulation in Bone Healing |
|
|
411 | (4) |
|
|
411 | (1) |
|
18.9.2 Electrical Stimulation Modalities for Bone Healing |
|
|
412 | (1) |
|
18.9.3 Pulsed Magnetic Stimulation for Bone Healing and Other Medical Conditions |
|
|
412 | (3) |
|
18.10 NI Respiratory (Pneumatic) Therapies |
|
|
415 | (1) |
|
|
415 | (1) |
|
|
416 | (1) |
|
18.11 US May Help Treat AD |
|
|
416 | (1) |
|
|
417 | (4) |
|
|
417 | (1) |
|
18.12.2 Human Hearing Characteristics |
|
|
417 | (1) |
|
18.12.3 HAs, Frequency Compensation, and Frequency FLowering Technologies |
|
|
418 | (2) |
|
|
420 | (1) |
|
18.13 "Smart" Wound Dressings |
|
|
421 | (1) |
|
18.14 Negative-Pressure Wound Therapy |
|
|
421 | (1) |
|
18.15 Gene Editing with CRISPR-Cas9 and CRISPR-Cpf1 as a Prospective Therapy for Genetic Diseases |
|
|
421 | (2) |
|
18.15.1 Genetic Disorders |
|
|
421 | (1) |
|
18.15.2 Correcting Chromosome Damage with Genetically Engineered CRISPR-Cas9 and CRISPR-Cpf1 Gene Editing Tools |
|
|
422 | (1) |
|
|
423 | (2) |
Bibliography |
|
425 | (38) |
Glossary |
|
463 | (22) |
Index |
|
485 | |